 WOODCLIFF LAKE, N.J.--BUSINESS WIRE--Eagle Pharmaceuticals, Inc. Eagle or the Company NASDAQ: EGRX today announced that TREAKISYM RI 50ml liquid formulation has been filed with the Pharmaceuticals and Medical Devices Agency PMDA in Japan. The application is based on the results of clinical studies investigating the safety and pharmacokinetics of TREAKISYM RTD administered by 10-minute intravenous infusion. We are pleased that the RI application has been submitted ahead of sched 